According to Zhitong Finance App News, Bide Pharmaceutical (688073.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 1,051 million yuan, up 7.37% year on year; net profit to mother was 164 million yuan, up 36.92% year on year; after deducting non-net profit of 143 million yuan, up 39.11% year on year; basic earnings per share were 1.90 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.